$27.46
1.355.17%
At Close: -
$27.30
-0.16-0.58%
After Hours: Aug 23, 5:24 PM EDT
15 minutes delayed
Akero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Akero Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-0.81 | $-0.90 | 10.0 % |
Mar 2024 | 2024-05-10 | $-0.90 | $-0.95 | 5.26 % |
Dec 2023 | 2024-02-29 | $-0.99 | $-0.86 | -15.1 % |
Sep 2023 | 2023-11-13 | $-0.71 | $-0.68 | -4.41 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Akero Therapeutics (AKRO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-0.81, which beat the estimate of $-0.90.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.